Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Armitage

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Diabetes, Obesity & Metabolism|June 9, 2022
Hospital costs associated with adverse events in people with diabetes in the UKMi Jun Keng, Jose Leal, Louise Bowman, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Decrements in health-related quality of life associated with adverse events in people with diabetesMi Jun Keng, Jose Leal, Louise Bowman, et al.
Trials|February 26, 2026
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetesVichithranie W Madurasinghe, Marion Mafham, Georgina Buck, et al.
BMJ (Clinical Research Ed.)|November 14, 2006
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people, Borislava Mihaylova, Andrew Briggs, et al.
Lancet (London, England)|May 25, 2005
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individualsBorislava Mihaylova, Andrew Briggs, Jane Armitage, et al.
Archives of Disease in Childhood|October 17, 2021
Description and evaluation of a pathway for unaccompanied asylum-seeking childrenAlice Jane Armitage, Jonathan Cohen, Michelle Heys, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2022
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial CohortMi Jun Keng, Jose Leal, Marion Mafham, et al.
BMJ Open|February 26, 2025
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetesEmily Sammons, Louise Bowman, William Stevens, et al.
Lancet (London, England)|February 1, 2011
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study, Jonathan Emberson, Derrick Bennett, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|June 9, 2022
Hospital costs associated with adverse events in people with diabetes in the UKMi Jun Keng, Jose Leal, Louise Bowman, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Decrements in health-related quality of life associated with adverse events in people with diabetesMi Jun Keng, Jose Leal, Louise Bowman, et al.
Trials|February 26, 2026
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetesVichithranie W Madurasinghe, Marion Mafham, Georgina Buck, et al.
BMJ (Clinical Research Ed.)|November 14, 2006
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people, Borislava Mihaylova, Andrew Briggs, et al.
Lancet (London, England)|May 25, 2005
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individualsBorislava Mihaylova, Andrew Briggs, Jane Armitage, et al.
Archives of Disease in Childhood|October 17, 2021
Description and evaluation of a pathway for unaccompanied asylum-seeking childrenAlice Jane Armitage, Jonathan Cohen, Michelle Heys, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2022
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial CohortMi Jun Keng, Jose Leal, Marion Mafham, et al.
BMJ Open|February 26, 2025
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetesEmily Sammons, Louise Bowman, William Stevens, et al.
Lancet (London, England)|February 1, 2011
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study, Jonathan Emberson, Derrick Bennett, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
Pageof 11